We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
352 hedge funds and large institutions have $4.37B invested in Axsome Therapeutics in 2025 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 104 increasing their positions, 115 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
221% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 28
39% more capital invested
Capital invested by funds: $3.15B → $4.37B (+$1.22B)
28% more call options, than puts
Call options by funds: $111M | Put options by funds: $86.5M
21% more funds holding
Funds holding: 292 → 352 (+60)
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
0.05% more ownership
Funds ownership: 76.73% → 76.78% (+0.05%)
10% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 115
Holders
352
Holders Change
+60
Holders Change %
+20.55%
% of All Funds
4.72%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.16%
New
90
Increased
104
Reduced
115
Closed
28
Calls
$111M
Puts
$86.5M
Net Calls
+$24.5M
Net Calls Change
-$35M
Top Buyers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$71.1M |
| 2 |
D.E. Shaw & Co
New York
|
+$60.1M |
| 3 |
O
OrbiMed
New York
|
+$44.1M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$41.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$39.9M |
